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Abstract
Background: To determine factors that predict adherence to a mind-body intervention in a
randomized trial.
Design: We analyzed adherence data from a 3-arm trial involving 135 generally healthy seniors
65–85 years of age randomized to a 6-month intervention consisting of: an Iyengar yoga class with
home practice, an exercise class with home practice, or a wait-list control group. Outcome
measures included cognitive function, mood, fatigue, anxiety, health-related quality of life, and
physical measures. Adherence to the intervention was obtained by class attendance and biweekly
home practice logs.
Results: The drop-out rate was 13%. Among the completers of the two active interventions,
average yoga class attendance was 77% and home practice occurred 64% of all days. Average
exercise class attendance was 69% and home exercise occurred 54% of all days. There were no
clear effects of adherence on the significant study outcomes (quality of life and physical measures).
Class attendance was significantly correlated with baseline measures of depression, fatigue, and
physical components of health-related quality of life. Significant differences in baseline measures
were also found between study completers and drop-outs in the active interventions. Adherence
was not related to age, gender, or education level.
Conclusion: Healthy seniors have good attendance at classes with a physically active intervention.
Home practice takes place over half of the time. Decreased adherence to a potentially beneficial
intervention has the potential to decrease the effect of the intervention in a clinical trial because
subjects who might sustain the greatest benefit will receive a lower dose of the intervention and
subjects with higher adherence rates may be functioning closer to maximum ability before the
intervention. Strategies to maximize adherence among subjects at greater risk for low adherence
will be important for future trials, especially complementary treatments requiring greater effort
than simple pill-taking.
Background
Adherence is an important consideration in clinical trial
design, especially concerning mind-body interventions. A
meta-analysis of adherence to a range of medical interven-
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increases the likelihood of a good outcome by 26%[1] The
effect of high adherence on better health outcomes has
even been documented in the placebo arm of a double
blind randomized trials [2-4]. Subject characteristics that
determine adherence to drug treatment regimens and
behavioral interventions have been found to include psy-
chological states such as depression, anxiety, and psycho-
logical distress; cognitive-motivational factors such as
health beliefs, intentions, and self-efficacy; somatic and
cognitive appraisals such as perceived physical fitness and
adverse side effects of a treatment; and health-oriented
behaviors [5]. In a mind-body intervention, where greater
effort than simple pill-taking is required, factors that pre-
dict adherence and strategies to maximize adherence
deserve special attention. One reason is that adherence is
lower with behavioral interventions than with pill-taking
[6] and adherence may contribute to the effectiveness of
the intervention. The other is that the relationship
between adherence and health outcomes may itself be
mediated through mind-body mechanisms, with poten-
tial roles for expectancy, self-efficacy, and interest in
health promoting activities. These interactions, if not ade-
quately controlled for, may potentially confound results
of mind-body trials, especially since the trials are not
blinded to the participants out of necessity. For example,
if there is a large adherence effect on the outcomes, it may
be necessary to stratify allocation to better match adher-
ence in the groups. The present study investigates corre-
lates of adherence to yoga and exercise interventions in a
population of healthy seniors, contributing evidence for
baseline measures including mood, physical functioning,
general health, and fatigue impacting adherence rates and
probability of study completion.
Methods
The adherence data presented here were collected from a
recently reported 3-arm clinical trial [7]. The study con-
sisted of 135 generally healthy men and women 65–85
years of age randomized to a 6-month intervention con-
sisting of: an Iyengar yoga class along with home practice,
an exercise class along with home practice, or a wait-list
control group given the option of enrolling in either of the
active interventions after the wait-list period. As reported
[7], the yoga intervention produced improvement in qual-
ity of life and physical measures but not on cognition or
mood.
Subjects in the yoga intervention were taught beginning
Iyengar hatha yoga poses in weekly 90-minute classes.
Daily home practice was strongly encouraged, and sub-
jects were given a booklet illustrating the specific poses to
help with their independent practice [8]. Subjects in the
exercise intervention engaged in aerobic walking on an
outdoor track in weekly 60-minute classes. Daily home
exercise in the same range of perceived exertion was
encouraged at least 5 times per week. Subjects in the wait-
list group participated in no active intervention. All sub-
jects received monthly phone calls to assess for changes in
health.
Baseline assessments of study outcome measures were
performed before subjects were randomized and occurred
1 to 30 days before classes started. On the baseline visit,
medical history was reviewed, demographic data were
recorded, and the oral reading on the Wide Range
Achievement Test, 3rd edition (WRAT-3) [9], was admin-
istered to assess equality of educational achievement in
the three intervention groups. All outcome assessments
were done at baseline and 6 months. There was also a 3-
month visit primarily designed to encourage subjects'
continued participation in the study
Outcome measures included cognitive function, mood as
assessed by Center for Epidemiologic Studies Depression
Scale (CESD-10) [10] and Profile of Mood States (POMS)
[11], fatigue as assessed by Multidimensional Fatigue
Inventory (MFI-20) [12], state and trait anxiety (STAI)
[13], health-related quality of life (SF-36) [14], and phys-
ical measures (seated forward bend, one legged-standing).
Adherence to the each of the active interventions was
obtained by class attendance and biweekly home practice
logs. In a similar manner to other published trials of phys-
ical activity with measures of adherence (e.g., Martin and
Sinden [15]) the percent of days home practice occurred
(frequency) and the average length of home practice ses-
sions (duration) were calculated.
Results
Subject demographics and adherence data are summa-
rized in Table 1. 135 subjects were randomized and 118
completed the study by participating in the 6-month
assessment, yielding a total drop-out rate of 13%. Attri-
tion rates from the yoga, exercise, and wait-list groups
were 14%, 19%, and 5%, respectively, not significantly
different by chi-square. Within the two active interven-
tions, adherence data were available from 36 of the 38
completers in the yoga condition and all 38 completers in
the exercise condition. For the yoga group, average attend-
ance at classes was 77% and home practice occurred on
64% of all days, while for the exercise group class attend-
ance was 69% and home exercise occurred on 54% of all
days (or 76% of the five days a week it was recom-
mended). The adherence differences between the yoga
and the exercise group did not reach statistical significance
(for percent attendance, t = -1.94, p = 0.056 and for per-
cent days practiced out of all days possible, t = -1.822, p =
0.073). Home practice sessions lasted an average of 38
minutes for the yoga group and 56 minutes for the exer-
cise group (t = 3.8, p = .0003). The objective measure ofPage 2 of 7
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ures of adherence: number of days and length per day
(Wilcoxon, p's < 0.0005). Class attendance was selected
for the primary analyses because it was the most objective
measure.
Adherence as measured by class attendance was signifi-
cantly correlated with several baseline measures including
mood, physical aspects of quality of life, and measures of
fatigue (see Table 2). Higher baseline scores on self-rated
measures of depression and fatigue were associated with
lower class attendance during the 6 months of the inter-
vention, while there was a positive relationship between
adherence and self-rated measures of physical function-
ing, general health, vitality, and vigor at baseline.
Additionally, baseline measures of physical function and
fatigue were significantly different between subjects who
completed the study and those who dropped out (see
Table 3). At baseline, those subjects who went on to com-
plete the study scored higher on self-rated measures of
physical functioning and general health, and lower on
self-rated measures of trait anxiety and general fatigue,
than those subjects who eventually dropped out. Of inter-
est, completers had a higher mean baseline rating of bod-
ily pain on the SF-36 questionnaire than did drop-outs.
Operationalized as either class attendance or study com-
pletion, adherence was not related to age, gender, or edu-
cation level. There was no obvious effect of adherence on
the significant outcomes from the intervention (quality of
life and physical measures), defining class attendance
continuously or as a threshold (adherers greater than 60%
class attendance).
A limited number of subjects (n = 29) also completed a
five-factor personality inventory, the NEO PI-R [16]. No
significant relationships between adherence and person-
ality were found (Pearson's correlation, all p values greater
than 0.25), although the small sample size constrained
the power to determine an effect.
Discussion
Consistent with other reports of behavioral treatments
[17], adherence to yoga and exercise interventions in this
clinical trial was significantly correlated with baseline var-
iables including depression, fatigue, and physical aspects
of quality of life. Demographic variables were not reliable
predictors of adherence. It has been previously noted that
factors that can be changed, such as mood and social sup-
port, more strongly influence adherence than factors that
cannot, such as age and gender [18]. While adherence in
the present study was relatively low compared to what
might be expected in a drug trial, adherence has been
observed to be generally lower in behavioral interventions
and also with more objective adherence measures com-
pared to self-report [18]. For this reason, we relied on
objective class attendance as our primary adherence meas-
ure although the two self-reported measures were highly
correlated with the objective measure.
The underlying mechanisms associated with greater
adherence are not well understood. Because lower adher-
ence, even in the placebo arm of a double blind trial, is
associated with worse outcomes including greater mortal-
ity [2-4], it has been postulated that those with greater
adherence may engage in many other health promoting
behaviors. Thus, adherence may be a marker for a person-
ality or related trait related to motivation or goal-directed
behaviors. Self-efficacy, which may relate to motivation, is
the perceived confidence in one's ability to accomplish a
specific task [19]. While self-efficacy was not assessed in
this study, it has been shown to be an important correlate
of adherence [20]. Within the conceptual framework of
self-efficacy, adherence is promoted by the belief that an
intervention will be effective (the outcome expectancy) as
well as the belief that the individual is capable of follow-
ing the requirements of the intervention (the efficacy
expectancy). When these expectations of success contrib-
ute to high self-efficacy, high adherence can result, and
moreover, there is reciprocity; subjects who are highly
adherent to an intervention may be strengthening their
outcome and efficacy expectancies [21]. Expectancy of
Table 1: Subject demographics and adherence.
Exercise (n = 47) Yoga (n = 44) Wait-List (n = 44)
Age 73.7 ± 5.1 71.5 ± 4.9 71.2 ± 4.4
Gender 79% female 70% female 75% female
Years of Education 14.8 ± 2.8 15.5 ± 2.2 15.3 ± 2.8
WRAT-3 Reading 49.0 ± 4.0 48.7 ± 4.3 49.0 ± 3.4
Measures of Adherence:
Percent Classes Attended 69 % ± 19 % 77 % ± 20 % -
Percent Days Home Practice 54 % ± 26 % 64 % ± 22 % -
Average Daily Home Practice (min.) 56.1 ± 26.4 38.2 ± 10.4 -
Study completer vs. drop-out (% drop-out) 19% 14% 5%
Means ± SDs are reportedPage 3 of 7
(page number not for citation purposes)
BMC Complementary and Alternative Medicine 2007, 7:37 http://www.biomedcentral.com/1472-6882/7/37outcome, besides contributing to adherence, is also a
major component of the placebo effect [22,23]. Thus,
investigations of factors that predict adherence (or, for
that matter, all clinical investigations) are likely to benefit
from a good measure of expectancy, which was absent in
the present study. The relationship between adherence
and health outcomes may be due to mechanisms underly-
ing mind-body interactions, which makes this an area of
special interest for researchers conducting mind-body
interventions.
Many complementary treatments take a patient-centered
approach and utilize outcome and efficacy expectancies,
but also require greater effort than simple pill-taking, and
this unique set of qualities recommends controlling for
factors that impact adherence in mind-body interven-
tions. A discussion of adherence to Mindfulness-Based
Stress Reduction programs [24] has identified elements of
the intervention itself such as active participation, per-
sonal follow-up, accommodation of individual prefer-
ences, and emphasis on process instead of outcome,
which are believed to effectively discourage attrition and
relapse. These are common elements to other mind-body
therapies, including both physically active interventions
in the present study, which may contribute to differences
with conventional clinical trials in adherence and in out-
comes.
Improving adherence in a mind-body intervention has the
potential to enhance the treatment effect, by increasing
Table 2: Correlations of adherence (Percent Classes Attended) and baseline variables among study completers.
Exercise (n = 38) Yoga (n = 36) Both active interventions
Age -0.08 0.07 -0.07
Gender -0.20 0.12 -0.05
Years of Education -0.10 -0.29 -0.12
WRAT-3 Reading 0.18 -0.09 0.01
CES-D:10 -0.24 -0.36 -0.27
STAI
State Anxiety -0.08 -0.33 -0.20
Trait Anxiety -0.01 -0.41 -0.23
SF-36
Physical Functioning 0.21 0.52 0.38
Role-Physical 0.31 0.23 0.27
Bodily Pain 0.22 0.20 0.21
General Health 0.15 0.31 0.23
Vitality 0.23 0.38 0.32
Social Functioning 0.17 -0.04 0.09
Role-Emotional 0.19 0.16 0.18
Mental Health 0.17 0.13 0.13
Physical Composite 0.25 0.41 0.33
Mental Composite 0.15 0.09 0.13
POMS
Tension-Anxiety 0.12 -0.42 -0.16
Depression-Dejection -0.06 -0.15 -0.08
Anger-Hostility 0.06 -0.10 -0.01
Vigor 0.05 0.36 0.25
Fatigue -0.11 -0.52 -0.34
Confusion 0.01 -0.23 -0.12
Total Mood Disturbance -0.01 -0.36 -0.20
MFI-20
General Fatigue -0.33 -0.56 -0.44
Physical Fatigue -0.01 -0.34 -0.17
Reduced Activity -0.06 -0.38 -0.21
Reduced Motivation 0.06 -0.37 -0.17
Mental Fatigue -0.09 -0.32 -0.19
Correlation coefficients in bold are significant at p < 0.05Page 4 of 7
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cially those who (because of lower baseline functioning)
might sustain the greatest benefit and are at greater risk for
low adherence. These same subjects who may be most in
need of intervention may fail to even meet inclusion crite-
ria for some clinical trials where high adherence during a
screen-in period is required. In these cases, results of the
intervention can be difficult to generalize and potential
magnitude of the treatment effect may be obscured by the
relatively high baseline health status of subjects who do
pass the adherence run-in phase [3]. In the present study,
subjects with a profile of self-reported baseline scores that
was low on physical functioning and general health and
high on fatigue were more likely to drop out, and less
likely to maintain adherence if they did complete the
study. This pattern of results accords with other published
reports of factors that predict adherence to treatment,
implying that at least some commonly identified determi-
nants are equally relevant for mind-body interventions.
Reviews of efforts to improve adherence to therapeutic
regimens have thus far been inconclusive, and suggest that
no single approach is consistently effective for all subjects
in all interventions [25,26]. Strategies to promote adher-
ence include making instructions to subjects simpler and
less demanding, addressing cognitive-motivational fac-
tors such as self-efficacy and health beliefs, offering social
support and reinforcement, and providing reminders,
with results suggesting that highest success rates are
achieved by a combination of such approaches. Specific
Table 3: Active intervention completers and drop-outs compared on baseline variables.
Completers (n = 76) Drop-outs (n = 15) p-value
Age 72.4 ± 5.1 73.8 ± 5.1 0.33
Gender 74% female 80% female 0.61
Years of Education 15.0 ± 2.4 15.6 ± 3.3 0.48
WRAT-3 Reading 48.9 ± 3.9 48.1 ± 6.6 0.63
CES-D:10 4.9 ± 3.8 6.6 ± 4.4 0.14
STAI
State Anxiety 28.5 ± 8.6 33.0 ± 9.2 0.07
Trait Anxiety 29.5 ± 7.7 34.4 ± 8.4 0.03
SF-36
Physical Functioning 83.5 ± 13.0 72.5 ± 14.1 0.005
Role-Physical 78.6 ± 31.0 67.9 ± 34.6 0.24
Bodily Pain 74.8 ± 19.3 61.1 ± 19.3 0.02
General Health 81.0 ± 15.4 65.1 ± 13.7 0.001
Vitality 69.2 ± 16.0 65.7 ± 12.4 0.44
Social Functioning 91.9 ± 14.7 88.4 ± 18.0 0.43
Role-Emotional 82.0 ± 29.0 83.3 ± 25.3 0.87
Mental Health 84.1 ± 12.4 81.4 ± 12.4 0.45
Physical Composite 49.4 ± 7.0 42.7 ± 6.9 0.001
Mental Composite 54.7 ± 6.9 55.5 ± 6.3 0.69
POMS
Tension-Anxiety 0.8 ± 4.3 2.4 ± 4.5 0.19
Depression-Dejection 4.3 ± 5.4 4.8 ± 4.4 0.77
Anger-Hostility 3.7 ± 5.0 5.3 ± 5.9 0.31
Vigor 20.4 ± 4.8 19.1 ± 5.1 0.37
Fatigue 4.3 ± 3.8 5.6 ± 4.9 0.24
Confusion 0.4 ± 3.2 0.6 ± 2.4 0.88
Total Mood Disturbance -6.9 ± 19.8 -0.4 ± 21.4 0.27
MFI-20
General Fatigue 8.5 ± 3.5 10.5 ± 2.7 0.04
Physical Fatigue 7.8 ± 3.0 9.2 ± 3.1 0.11
Reduced Activity 8.1 ± 3.5 9.5 ± 3.1 0.14
Reduced Motivation 6.9 ± 2.7 8.1 ± 3.9 0.12
Mental Fatigue 7.7 ± 3.5 8.8 ± 2.7 0.24
Means ± SDs are reportedPage 5 of 7
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jects that may have more difficulty with adherence to
behavioral interventions because of a variety of issues
such as getting to a class, physical limitations, parental or
caregiver responsibilities, or, as already discussed, depres-
sion. Concerns such as these may be especially relevant for
elderly populations [27], like those tested in the present
study, who stand to gain greatly from improvements in
health. Continued attention to maximizing adherence is
important for enhancing treatment benefits, as well as
controlling the costs of clinical trials and increasing statis-
tical power to determine the effectiveness of interventions
[28].
This analysis examined study completion or attrition as
well as adherence to the terms of a physically active inter-
vention, and it may be that unique factors differentiate
correlates of these related measures. As previously men-
tioned, lower adherence, even in the placebo arm of a
double blind trial, is associated with worse outcomes [2-
4], although the underlying mechanisms linking adher-
ence to health outcomes are still unknown. Future trials
may elucidate this relationship, which could be related to
mind-body interactions.
Conclusion
Healthy seniors have reasonably good attendance at
classes with a physically active intervention. There were
no clear effects of adherence on the significant study out-
comes (quality of life and physical measures). Adherence
to the intervention was significantly correlated with base-
line measures of depression, fatigue, and physical compo-
nents of health-related quality of life. Adherence was not
related to age, gender, or education level. Decreased
adherence to a potentially beneficial intervention for
fatigue or depression has the potential to decrease the
effect of the intervention in a clinical trial because subjects
who might sustain the greatest benefit will receive a lower
dose of the intervention and subjects with higher adher-
ence rates may be functioning better before the interven-
tion. Strategies to maximize adherence among subjects at
greater risk for low adherence will be important for future
trials, especially complementary treatments requiring
greater effort than simple pill-taking.
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